Escalon Medical Corp Net Income
| ESMC Stock | USD 0.18 0.00 0.00% |
As of the 10th of February, Escalon Medical shows the Coefficient Of Variation of 985.56, standard deviation of 3.23, and Mean Deviation of 1.5. Escalon Medical Corp technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We have collected data for thirteen technical drivers for Escalon Medical Corp, which can be compared to its peers.
Escalon Medical's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Escalon Medical's valuation are provided below:Escalon Medical Corp does not presently have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Escalon |
Escalon Medical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Escalon Medical's otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Escalon Medical.
| 11/12/2025 |
| 02/10/2026 |
If you would invest 0.00 in Escalon Medical on November 12, 2025 and sell it all today you would earn a total of 0.00 from holding Escalon Medical Corp or generate 0.0% return on investment in Escalon Medical over 90 days. Escalon Medical is related to or competes with Cyduct Diagnostics, and DATATRAK International. Escalon Medical Corp. develops, manufactures, markets, and distributes medical devices and pharmaceuticals in the area o... More
Escalon Medical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Escalon Medical's otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Escalon Medical Corp upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.071 | |||
| Maximum Drawdown | 19.22 | |||
| Value At Risk | (5.88) | |||
| Potential Upside | 6.25 |
Escalon Medical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Escalon Medical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Escalon Medical's standard deviation. In reality, there are many statistical measures that can use Escalon Medical historical prices to predict the future Escalon Medical's volatility.| Risk Adjusted Performance | 0.0889 | |||
| Jensen Alpha | 0.2952 | |||
| Total Risk Alpha | (0.04) | |||
| Treynor Ratio | 1.25 |
Escalon Medical February 10, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0889 | |||
| Market Risk Adjusted Performance | 1.26 | |||
| Mean Deviation | 1.5 | |||
| Coefficient Of Variation | 985.56 | |||
| Standard Deviation | 3.23 | |||
| Variance | 10.43 | |||
| Information Ratio | 0.071 | |||
| Jensen Alpha | 0.2952 | |||
| Total Risk Alpha | (0.04) | |||
| Treynor Ratio | 1.25 | |||
| Maximum Drawdown | 19.22 | |||
| Value At Risk | (5.88) | |||
| Potential Upside | 6.25 | |||
| Skewness | 0.3459 | |||
| Kurtosis | 7.49 |
Escalon Medical Corp Backtested Returns
Escalon Medical appears to be out of control, given 3 months investment horizon. Escalon Medical Corp secures Sharpe Ratio (or Efficiency) of 0.0759, which denotes the company had a 0.0759 % return per unit of standard deviation over the last 3 months. We have found eighteen technical indicators for Escalon Medical Corp, which you can use to evaluate the volatility of the firm. Please utilize Escalon Medical's Coefficient Of Variation of 985.56, mean deviation of 1.5, and Standard Deviation of 3.23 to check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Escalon Medical holds a performance score of 6. The firm shows a Beta (market volatility) of 0.26, which means not very significant fluctuations relative to the market. As returns on the market increase, Escalon Medical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Escalon Medical is expected to be smaller as well. Please check Escalon Medical's standard deviation and the relationship between the jensen alpha and rate of daily change , to make a quick decision on whether Escalon Medical's price patterns will revert.
Auto-correlation | -0.06 |
Very weak reverse predictability
Escalon Medical Corp has very weak reverse predictability. Overlapping area represents the amount of predictability between Escalon Medical time series from 12th of November 2025 to 27th of December 2025 and 27th of December 2025 to 10th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Escalon Medical Corp price movement. The serial correlation of -0.06 indicates that barely 6.0% of current Escalon Medical price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.06 | |
| Spearman Rank Test | 0.19 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Escalon Medical Corp reported net income of 18.08 K. This is 99.99% lower than that of the Health Care Equipment & Supplies sector and 99.99% lower than that of the Health Care industry. The net income for all United States stocks is 100.0% higher than that of the company.
Escalon Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Escalon Medical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Escalon Medical could also be used in its relative valuation, which is a method of valuing Escalon Medical by comparing valuation metrics of similar companies.Escalon Medical is currently under evaluation in net income category among its peers.
Escalon Fundamentals
| Return On Equity | -0.42 | |||
| Return On Asset | -0.0724 | |||
| Profit Margin | (0.06) % | |||
| Operating Margin | (0.06) % | |||
| Current Valuation | 2.07 M | |||
| Shares Outstanding | 7.42 M | |||
| Shares Owned By Insiders | 1.90 % | |||
| Number Of Shares Shorted | 2.01 K | |||
| Price To Earning | 4.50 X | |||
| Price To Book | 1.12 X | |||
| Price To Sales | 0.05 X | |||
| Revenue | 10.7 M | |||
| Gross Profit | 4.61 M | |||
| EBITDA | 84.92 K | |||
| Net Income | 18.08 K | |||
| Cash And Equivalents | 593.87 K | |||
| Cash Per Share | 0.08 X | |||
| Total Debt | 153.43 K | |||
| Debt To Equity | 0.81 % | |||
| Current Ratio | 1.39 X | |||
| Book Value Per Share | 0.07 X | |||
| Cash Flow From Operations | (1.05 M) | |||
| Short Ratio | 0.31 X | |||
| Earnings Per Share | 0.02 X | |||
| Target Price | 7.0 | |||
| Number Of Employees | 41 | |||
| Beta | -0.39 | |||
| Market Capitalization | 404.06 K | |||
| Total Asset | 5.17 M | |||
| Retained Earnings | (66.22 M) | |||
| Working Capital | 1.36 M | |||
| Current Asset | 4.13 M | |||
| Current Liabilities | 2.78 M | |||
| Z Score | -13.6 | |||
| Net Asset | 5.17 M |
About Escalon Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Escalon Medical Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Escalon Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Escalon Medical Corp based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Escalon OTC Stock
Escalon Medical financial ratios help investors to determine whether Escalon OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Escalon with respect to the benefits of owning Escalon Medical security.